Pennsylvania Department of health urges expanded h1n1 vaccination efforts to include all patients – Certified healthcare providers who have already immunized patients most at risk of complications from the H1N1 flu virus may now offer the vaccine to anyone who wants it, the Department of Health announced today.
State Public Health Director Announces Expansion of H1N1 Flu Vaccine Availability to all Illinoisans — High-risk individuals encouraged to be vaccinated before expansion next week. – Illinois Department of Public Health Director Dr. Damon T. Arnold announced that beginning Tuesday, December_15, 2009, all Illinoisans will be eligible to receive an H1N1 flu vaccination.
FDA Approves Agriflu Seasonal Influenza Vaccine — Another option to prevent illnesses caused by subtypes A and B influenza virus – The U.S. Food and Drug Administration approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B.
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility – Novartis inaugurated the US’s first ever large-scale flu cell culture vaccine and adjuvant manufacturing facility in Holly Springs, North Carolina.
Monitoring of human swine influenza virus in connection with a recent Norway report – The Hong Kong’s Public Health Laboratory Service Branch (PHLSB) had detected one human swine influenza (HSI) virus which had the same mutation as the one detected in Norway recently.
Safety of pandemic vaccines — Pandemic (H1N1) 2009 briefing note 16. – WHO estimates that around 80 million doses of pandemic vaccine have been distributed and around 65 million people have been vaccinated. National immunization campaigns began in Australia and the People’s Republic of China in late September.
La Jolla Institute finds previous seasonal flu infections may provide some level of H1N1 immunity – Previous influenza infections may provide at least some level of immunity to the H1N1 “swine” flu, revealed by researchers at the La Jolla Institute for Allergy & Immunology, US.
HIV vaccine failure probably caused by virus used, says new research – The recent failure of an HIV vaccine was probably caused by the immune system reacting to the virus ‘shell’ used to transmit the therapy around the body, revealed by researchers.
Shri Azad launches special polio vaccine drive on children?s day — Bi-valent OPV to be introduced soon to tackle rise in polio cases. – The Indian Minister of Health and Family Welfare Shri Ghulam Nabi Azad said that the Indian Government will very soon introduce bi-valent oral polio vaccine to attack the type 1 and type 3 virus to deal with the fresh outbreak of type 3 virus.
With 29 fresh cases being reported Sunday, reaching the total number of those suffering from dengue fever to 812 in New Delhi, India. – Dengue fever has affected more than 800 people in Delhi – capital of India. Health officials confirmed 29 new cases of dengue infection reaching to 812 cases of debgue fever in this season.
FDA Expands Approved Use of H1N1 Vaccines to Include Infants and Children – US FDA has approved the use of the CSL Limited’s 2009 H1N1 influenza vaccine to include children ages 6 months and older. This vaccine was previously approved only for use in adults, ages 18 years and older.
FDA-approved drugs fulvestrant and raloxifene eliminate, prevent cervical cancer in mice. – Researchers eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and osteoporosis. The study is published in the Proceedings of the National Academy of Sciences.
